DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Sternberg CN. et al.
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update.
Eur J Cancer 2013;
49: 1287-1296
We do not assume any responsibility for the contents of the web pages of other providers.